Evidence map›Paper›PMID 38051968›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Infectious Inequity: How the Gut Microbiome and Social Determinants of Health May Contribute to Clostridioides difficile Infection Among Racial and Ethnic Minorities.

Kelly R Reveles, Kelsey A Strey, Jacinda C Abdul-Mutakabbir, V Mateo Mendoza, Joseph J Carreno

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Kelly R RevelesPharmacotherapy Division, College of Pharmacy, University of Texas at Austin, Austin, Texas, USA.
Kelsey A StreyPharmacotherapy Division, College of Pharmacy, University of Texas at Austin, Austin, Texas, USA.
Jacinda C Abdul-MutakabbirDivision of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, La Jolla, California, USA.
V Mateo MendozaPharmacotherapy Division, College of Pharmacy, University of Texas at Austin, Austin, Texas, USA.
Joseph J CarrenoDepartment of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York, USA.
The University of Texas at Austin · USAlbany College of Pharmacy and Health Sciences · USThe University of Texas Health Science Center at San Antonio · USUniversity of California San Diego · US

Funding

UC San Diego RAPID Faculty Development Program in Infectious DiseasesR25AI147376 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADRIANA H TREMOULET, Joann Trejo · 2020 to 2026
$2.5M
NIAID NIH HHS R25 AI147376
6 · The paper itself

Abstract

Infectious diseases are a leading contributor to death in the United States, and racial differences in clinical outcomes have been increasingly reported. Clostridioides difficile infection (CDI) is a growing public health concern, as it causes nearly half a million infections per year and considerable excess hospital costs. Concurrent with other infectious diseases, recent literature denotes racial disparities in CDI incidence rates, mortality, and associated morbidity. Of note, investigations into CDI and causative factors suggest that inequities in health-related social needs and other social determinants of health (SDoH) may cause disruption to the gut microbiome, thereby contributing to the observed deleterious outcomes in racially and ethnically minoritized individuals. Despite these discoveries, there is limited literature that provides context for the recognized racial disparities in CDI, particularly the influence of structural and systemic barriers. Here, we synthesize the available literature describing racial inequities in CDI outcomes and discuss the interrelationship of SDoH on microbiome dysregulation. Finally, we provide actionable considerations for infectious diseases professionals to aid in narrowing CDI equity gaps.

Indexed as

Clostridium InfectionsCommunicable DiseasesGastrointestinal MicrobiomeEthnic and Racial MinoritiesHumansSocial Determinants of HealthClostridioides difficilehealth disparitiesinfectious diseasesmicrobiomesocial determinants of health

Identifiers

PMID38051968
PMCPMC10697666
OpenAlexW4389330813

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.